---
title: Heparins are potent inhibitors of ectonucleotide pyrophosphatase/phospho-diesterase-1
  (NPP1) - a promising target for the immunotherapy of cancer
date: '2023-09-15'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37711611/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230915181246&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'INTRODUCTION: Heparins, naturally occurring glycosaminoglycans, are
  widely used for thrombosis prevention. Upon application as anticoagulants in cancer
  patients, heparins were found to possess additional antitumor activities. Ectonucleotidases
  have recently been proposed as novel targets for cancer ...'
disable_comments: true
---
INTRODUCTION: Heparins, naturally occurring glycosaminoglycans, are widely used for thrombosis prevention. Upon application as anticoagulants in cancer patients, heparins were found to possess additional antitumor activities. Ectonucleotidases have recently been proposed as novel targets for cancer ...